VAN ECK ASSOCIATES CORP - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 51 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$37,000
-32.7%
7,849
+1.5%
0.00%
Q4 2020$55,000
-68.0%
7,733
-52.6%
0.00%
Q3 2020$172,000
+21.1%
16,298
+2.1%
0.00%
Q2 2020$142,000
+688.9%
15,958
+232.3%
0.00%
Q1 2020$18,0000.0%4,802
+3.5%
0.00%
Q4 2019$18,000
+5.9%
4,638
+0.8%
0.00%
Q3 2019$17,0004,6020.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 837,898$1,734,0000.84%
Green Alpha Advisors, LLC 78,159$162,0000.11%
Values First Advisors, Inc. 49,485$102,0000.06%
SHELTON CAPITAL MANAGEMENT 128,532$266,0000.01%
Archford Capital Strategies, LLC 13,091$29,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$347,0000.01%
Halpern Financial, Inc. 5,800$12,0060.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$145,0000.00%
TOWNSQUARE CAPITAL LLC 23,938$50,0000.00%
Newbridge Financial Services Group, Inc. 1,200$2,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders